- Run for Goodness
- HOMEPAGE
- WHO ARE WE?
-
WHAT ARE WE DOING?
- Support Application
- Medical Device Supports
- Medical Material Supports
- "We Are With You" Boxes
- Rental Support
- Other Supports
- Stationery Supports
- Education Scholarship
- Carrier Scan
- Newborn Screening
- Nusinersen Sodium Application Centers
- PGT
- TBMM Research Commission
- Visit / Meetings
- Our Memberships
- Seminars
- SMA Awareness Month
- I SMA Movie
- Our Publications
- Projects
- HOW CAN YOU SUPPORT?
-
SMA
Evrysdi with the active ingredient Risdiplam, one of the 3 treatment methods approved by EMA and FDA, used in the treatment of SMA disease, 0.75 mg/mL Powder for Preparing Oral Solution, 80 ML, by TITCK on 18.10.2024 has been licensed.
With the update made on 25.12.2024, this treatment is now licensed for the use of 0-2 month old babies.
